Form 4 Tracker
Adaptive Biotechnologies Corp
ADPT

58 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 29, 2026Jun 29 8:48 PMSHARON BENZENO
Proposed Sale
152,931$20.96$3.2M

View →

Jun 26, 2026Jun 26 8:42 PMSHARON BENZENO
Proposed Sale
12,871$20.25$260.6K

View →

Jun 25, 2026Jun 25 8:26 PMSUSAN BOBULSKY
Proposed Sale
5,000$19.34$96.7K

View →

Jun 25, 2026Jun 25 8:26 PMMICHELLE GRIFFIN
Proposed Sale
52,084$19.34$1.0M

View →

Jun 16, 2026Jun 18 12:11 AMHarlan S RobinsChief Scientific Officer
Sale
6,160$18.01$110.9K1,405,898(D)

View →

Jun 15, 2026Jun 18 12:11 AMHarlan S RobinsChief Scientific Officer
Sale
100,000$17.37$1.7M1,412,058(D)

View →

Jun 16, 2026Jun 16 10:04 PMHarlan Robins
Proposed Sale
6,160$17.22$106.1K

View →

Jun 11, 2026Jun 15 11:13 PMSusan BobulskyChief Commercial Officer, MRD
Sale
5,000$19.00$95.0K411,775(D)

View →

Jun 15, 2026Jun 15 10:10 PMHarlan Robins
Proposed Sale
100,000$17.46$1.7M

View →

Jun 11, 2026Jun 11 8:37 PMSUSAN BOBULSKY
Proposed Sale
5,000$17.07$85.3K

View →

Jun 4, 2026Jun 9 12:29 AMFrancis LOChief People Officer
Sale
39,741$17.49$695.1K250,934(D)

View →

Jun 4, 2026Jun 9 12:27 AMSusan BobulskyChief Commercial Officer, MRD
Sale
11,000$18.00$198.0K416,775(D)

View →

Jun 4, 2026Jun 4 8:34 PMSUSAN BOBULSKY
Proposed Sale
11,000$15.99$175.9K

View →

Jun 4, 2026Jun 4 8:27 PMFRANCIS LO
Proposed Sale
42,085$15.99$672.9K

View →

May 18, 2026May 20 11:13 PMKyle PiskelChief Financial Officer
Sale
3,115$13.04$40.6K256,725(D)

View →

May 18, 2026May 16 12:03 AMPISKEL KYLE
Proposed Sale
3,160$12.83$40.5K

View →

Apr 27, 2026Apr 29 11:08 PMJulie RubinsteinPresident and COO
Sale
19,037$14.23$270.9K377,802(D)

View →

Apr 24, 2026Apr 24 10:29 PMJulie RubinsteinPresident and COO
Sale
19,060$14.02$267.2K382,132(D)

View →

Apr 23, 2026Apr 24 10:29 PMJulie RubinsteinPresident and COO
Sale
19,060$13.74$261.9K386,470(D)

View →

Apr 22, 2026Apr 24 10:29 PMJulie RubinsteinPresident and COO
Sale
19,060$14.13$269.3K390,808(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 12, 2026Mar 14 1:36 AMJulie RubinsteinPresident and COO
Option Exercise
14,722$6.5577,549(D)

View →

Mar 11, 2026Mar 14 1:36 AMJulie RubinsteinPresident and COO
Option Exercise
14,722$6.5592,271(D)

View →

Mar 10, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
15,122$12.14403,539(D)

View →

Mar 9, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14403,939(D)

View →

Mar 6, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14415,820(D)

View →

Mar 3, 2026Mar 6 1:05 AMMichelle Renee GriffinDirector
Option Exercise
48,044$3.990(D)

View →

Mar 5, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14427,701(D)

View →

Mar 4, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14439,582(D)

View →

Mar 3, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14451,463(D)

View →

Feb 4, 2026Feb 7 12:30 AMKyle PiskelChief Financial Officer
Option Exercise
2,145$12.142,146(D)

View →

← Previous

Page 3 of 3